Severe tissue injury is characterized by an intense inflammatory
response leading to a systemic inflammatory
response. Various drugs that decrease inflammation like recombinant
human activated protein C (APC), IL-1 receptor
antagonist, anti-TNF and anti-LPS agents are not found to be
effective in bleeding trauma patients